In patients with CESC, CHOL, ESCA, GBM, LUAD, MESO, SARC, and STAD, either low-level methylation or no methylation of FUBP1 was observed, indicating the high expression of FUBP1 in the abovementioned cancer types (Figure 4). Here, FUBP1 is linked to cervical squamous cell carcinoma.